XCUR (Exicure Corp) Net Financial Result

XCUR (Exicure, Inc.) - company brandmark

The absence of stable revenue streams and the search for new growth vectors create an uncertain market backdrop for Exicure, Inc. (XCUR). The company's current net result on this chart visualizes this volatility, where -0.01 shows the current volume of the metric. Stability is provided by partnerships with industry behemoths in the field of genetics, while unique spherical platforms allow drugs to penetrate tissues without specialized carriers.

Exicure (XCUR): Net Income from 07/04/2022 to 10/30/2026
Manufactured products of Exicure, Inc.

To minimize fundamental risks, investors should select assets with stable cash flows where calculated profit reflects the real-time difference between total revenues and operating expenses. On the GURU.Markets platform, the final financial result of Exicure, Inc. (XCUR) demonstrates a depressive efficiency plateau, as the lack of operating leverage following the reduction of R&D projects hinders profit growth amid high unit costs.

Direct competitors

Company Profit TEM|QGEN (Qiagen N.V.) - Net Profit|ionispharma.com (IONS) - Net Financial Result|Net Profit RGEN|Net Income Avidity Biosciences Inc RNA|CRISPR Therapeutics Corp - Net Income|Net Profit GeneDx Corp WGS|RARE - Company Net Income|Final Profit BEAM (beamtx.com)|SRPT: Net Profit|Company Net Income Twist Bioscience Inc (TWST)|Net Income TXG|NTLA: Final Profit|Net Profit STOK|Net Financial Result biolifesolutions.com|Company Net Income Wave Life Sciences Ltd. WVE|MAZE: Company Profit|Sionna Pharma - Net Profit|Prime Medicine Bio (PRME) - Net Income|TSHA (Taysha Gene Therapies) - Net Income|QURE - Net Financial Result|Net Income MGTX|Company Profit RGNX (REGENXBIO Inc)|Net Profit SLDB|Net Income Ocugen Pharma OCGN|Pacific Biosciences - Net Income|Net Profit benitec.com BNTC|DSGN - Company Net Income|Final Profit RCKT (Rocket Pharma)|FDMT: Net Profit|Company Profit LXEO|Company Net Income Korro Bio Inc.|Company Profit EDIT (editasmedicine.com)|Net Profit SLN|Net Profit proqr.com (PRQR)|Net Profit CDXS (Codexis)|Sangamo BioSciences (SGMO) - Company Net Income|NAUT: Net Income|MGX (metagenomi.co) - Company Profit|DTIL: Net Profit|GBIO - Net Financial Result|BOLD (Boundless Bio, Inc) - Net Profit|Net Income Celsion Corporation (IMNN)|Net Income PHIO (Phio Pharmaceuticals)|Net Profit mustangbio.com (MBIO)|Company Net Income TransCode Therapeutics, Inc. RNAZ|Final Profit BNGO|Applied DNA - Net Profit|Company Net Income bluebird bio, Inc|IPA (immunoprecise.com) - Net Income|omegatherapeutics.com - Final Profit|OMIC (Singular Genomics) - Net Profit|Regulus Therapeutics, Inc. (RGLS) - Net Financial Result|Company Net Income Syros (SYRS)|Telesis Bio, Inc - Company Profit|Net Profit TCON (TRACON Pharmaceuticals)|UBX - Net Income